JP2024517085A5 - - Google Patents
Info
- Publication number
- JP2024517085A5 JP2024517085A5 JP2023562607A JP2023562607A JP2024517085A5 JP 2024517085 A5 JP2024517085 A5 JP 2024517085A5 JP 2023562607 A JP2023562607 A JP 2023562607A JP 2023562607 A JP2023562607 A JP 2023562607A JP 2024517085 A5 JP2024517085 A5 JP 2024517085A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174005P | 2021-04-12 | 2021-04-12 | |
| US202163174004P | 2021-04-12 | 2021-04-12 | |
| US63/174,004 | 2021-04-12 | ||
| US63/174,005 | 2021-04-12 | ||
| PCT/US2022/024079 WO2022221143A1 (en) | 2021-04-12 | 2022-04-08 | Wee1 compound for treating uterine serous carcinoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024517085A JP2024517085A (ja) | 2024-04-19 |
| JPWO2022221143A5 JPWO2022221143A5 (https=) | 2025-04-09 |
| JP2024517085A5 true JP2024517085A5 (https=) | 2025-04-09 |
Family
ID=83640600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562607A Pending JP2024517085A (ja) | 2021-04-12 | 2022-04-08 | 子宮漿液性がんを治療するためのｗｅｅ１化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240197743A1 (https=) |
| EP (1) | EP4322958A4 (https=) |
| JP (1) | JP2024517085A (https=) |
| AU (1) | AU2022259496A1 (https=) |
| CA (1) | CA3213804A1 (https=) |
| TW (1) | TW202304455A (https=) |
| WO (1) | WO2022221143A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020384291A1 (en) | 2019-11-15 | 2022-05-26 | Recurium Ip Holdings, Llc | Chiral synthesis of a tertiary alcohol |
| BR112023000350A2 (pt) | 2020-07-09 | 2023-03-28 | Recurium Ip Holdings Llc | Sais e formas de um inibidor de wee1 |
| EP4615459A4 (en) * | 2022-11-08 | 2026-04-29 | Zeno Man Inc | Intermittent dosing regimen for azenosertib in treating cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020009372A (es) * | 2018-03-09 | 2020-10-14 | Recurium Ip Holdings Llc | 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-onas sustituidas. |
| US12318452B2 (en) | 2018-09-27 | 2025-06-03 | Dana-Farber Cancer Institute, Inc. | Degraders of WEE1 kinase |
| WO2020210320A1 (en) * | 2019-04-11 | 2020-10-15 | Recurium Ip Holdings, Llc | Substituted l,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones |
-
2022
- 2022-04-08 AU AU2022259496A patent/AU2022259496A1/en active Pending
- 2022-04-08 EP EP22788687.6A patent/EP4322958A4/en active Pending
- 2022-04-08 CA CA3213804A patent/CA3213804A1/en active Pending
- 2022-04-08 JP JP2023562607A patent/JP2024517085A/ja active Pending
- 2022-04-08 US US18/554,951 patent/US20240197743A1/en active Pending
- 2022-04-08 WO PCT/US2022/024079 patent/WO2022221143A1/en not_active Ceased
- 2022-04-11 TW TW111113723A patent/TW202304455A/zh unknown